Rx Product News Profile: A Closer Look at New FDA Actions: Centocor Ortho Biotech's Stelara
February 16th 2010The FDA recently approved Centocor Ortho Biotech's Stelara (ustekinumab)for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
The Antibiotic Minimalist: The Patient as Partner
February 16th 2010Alternative treatments are available for fighting common viral infections-patients who are educated about these options can overcome the infection without antibiotics. Pharmacists can provide education and join local or national campaigns to help patients avoid antibiotic misuse.
Specialty Pharmaceuticals: Therapy Class Review: Hepatitis C Treatment Guidelines
February 16th 2010The pharmacist plays an important role in the pharmaceutical care of patients undergoing treatment for hepatitis C virus (HCV). The new American Association for the Study of Liver Diseases Practice Guidelines are a wealth of information about HCV and provide an invaluable foundation for the care of these patients.
Drug Diversion and Abuse: Pseudoephedrine Tracking System-NPLEx
February 15th 2010Although restrictions on the sale of pseudoephedrine products have been in place for several years, diversion of these products still occurs-a new electronic tracking system holds the promise to help curb this crime.
Rigorous Standards for Bioequivalence
February 15th 2010Although questions have been raised regarding the safety and efficacy of generic drugs, compared with their brand drug counterparts, the FDA supports the bioequivalence of generic drugs and is helping to deliver important information to patients.
Drug Interactions: Clopidogrel-Proton Pump Inhibitor Interaction: An Update
February 15th 2010This column is an update to the April 2008 column that discussed the possible interaction between clopidogrel and proton pump inhibitors-new studies and data are brought into perspective.